N2Growth Blog

FEBRUARY 4, 2015

A move toward the Advantage Strategy Paradigm begins with the adoption and commitment to a set of principles that guides all executives in the decisions and actions they take related to developing, planning, and executing strategy. How many more times do people have to hear it before it actually becomes a priority? That is the good news.

Process 150

Process Agility Competitive Advantage Strategy 150

Marshall Goldsmith

FEBRUARY 8, 2018

Deepa Prahalad – Focused on design and emerging markets. 14th Administrator, United States Agency for International Development. Rod MacKenzie – Executive Vice President, Chief Development Officer for Pfizer, member of Pfizer’s Executive Leadership Team. HR and talent development roles with General Motors Australia.

Executive Coaching 70

Executive Coaching CEO Banking Magazine 70

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. You must appeal to all of these audiences.

Tactics 51

Tactics Execution Pharmaceuticals Human Capital 51

Lead on Purpose

SEPTEMBER 8, 2009

And I can assure you that the advice I share with you today has stood the test of time… It helped me inspire my Weatherchem team to create the original Flapper® dispensing closure. Filed under: Integrity , Leadership , Purpose , Team Building , Trust Tagged: | Albert J. Theme: Digg 3 Column by WP Designer.

Committee 140

Committee Automotive Ethics Products 140

Tanveer Naseer

MARCH 10, 2015

For example, they might say, “We’re a bank,” or “We make office furniture,” or “We’re in the pharmaceutical business.” Most senior executives respond to this question by describing what the company is or what it does. This is quite understandable. It’s the most simple and straightforward reply to the question. Jeff Bezos gets this, too.

How To 100

How To Retail Core Competence Innovation 100

Harvard Business Review

JULY 17, 2014

When Raja Rajamannar became CMO of MasterCard Worldwide in 2013, he moved quickly to transform how the credit card giant measures marketing. But the real power and full potential of data was not being fully realized by marketing. As an ingredient brand, Intel often struggled to link marketing to P&L impact. Inside Intel.

Finance 13

Finance Marketing P&L ROI 13

Harvard Business Review

JANUARY 15, 2016

I teach at Rutgers University in New Jersey, the epicenter for many major companies in pharmaceuticals, insurance, and banking. The companies who re-organize and adjust for today’s market realities and customer needs will win. This is an excruciating marketing environment. And yet BPV is a content marketing machine.

Industry 8

Industry Marketing Company Compliance 8

Harvard Business Review

MAY 7, 2015

A telecom company developed a collaborative filtering model, similar in concept to predictive algorithms used by companies such as Netflix and Amazon, to help key account salespeople. This information improved marketing campaign targeting, as well as sales force targeting. Consider three examples. “data doubles”).

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

QAspire

JANUARY 24, 2010

He was a marketing executive with a large pharmaceutical company when he decided to pursue his calling and start a fitness center. What started as a two member team was now a successful fitness center running round the clock with a number of trained instructors and some very good facilities.

Directory 82

Directory Blog Pharmaceuticals Quality 82

Harvard Business Review

JUNE 13, 2016

No matter how you look at it, there have been terrible, unintended outcomes from the introduction and marketing of next-generation prescription opioids. Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

MARCH 18, 2018

Why the Pharmaceutical Industry Is Booming in Japan. Japan already enjoys the world’s second-biggest market in medical devices. percent of the 2014 global medical device market—behind the U.S. Philips, the Dutch electronics and health care corporation, is among the foreign companies attracted to Japan’s market.

Health Care 8

Health Care Industry Pharmaceuticals Content 8

Harvard Business Review

OCTOBER 6, 2016

Investments in traditional leadership development are often misguided and a waste of money. It’s not that development itself isn’t important. So they’re looking for ways to cultivate those competencies and, in the process, feeding the fad-driven leadership development market. Paul Garbett for HBR.

Leadership Pipeline 13

Leadership Pipeline Leadership After Action Review Pharmaceuticals 13

Harvard Business Review

JULY 28, 2015

Avoid generic terms such as results-driven , proven track record , excellent communication skills , team player. Lead global marketing and commercial operations teams with P&Ls up to $2B.” Develop award-winning, injury-reducing ergonomic equipment. .” Include years of experience. ” Further Reading.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

SEPTEMBER 12, 2012

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. But why not?

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

FEBRUARY 16, 2017

Most businesses wouldn’t survive without driving demand for their products or services, either through marketing and advertising or through involving users so deeply in the design of the product that word of mouth spurs adoption. adults were at risk of developing type 2 diabetes in 2015. The same is true for social innovators.

Innovation 9

Innovation Rogers NGO Participative 9

Harvard Business Review

AUGUST 14, 2018

However, they have all failed in China, the world’s largest digital market. Google, for example, has succeeded in dominating many foreign markets that have radically different political systems and cultures (including Indonesia, Thailand, and Saudi Arabia). imposing technological platforms developed for the U.S.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

SEPTEMBER 21, 2015

Terry, a highly regarded marketing associate in a pharmaceutical firm, had just been asked to lead a marketing team. But problems arise when there’s no ongoing dialogue with team members, peers, and bosses about the definition of “success” and “results”— and who is responsible for what.

Management 8

Management Pharmaceuticals Learning-by-Doing Marketing 8

Harvard Business Review

SEPTEMBER 4, 2017

You and Your Team Series. Confronted with intense levels of stress amidst turbulent change or the headwinds of a harsh market, leaders’ fuses get short. During an onslaught of major change, sources of irritation can often be circumstances outside anyone’s control, like changing regulatory requirements or a market slow down.

Supply Chain 15

Supply Chain Self-aware Loyalty Stress 15

Harvard Business Review

SEPTEMBER 23, 2014

Take the case of Janssen, the pharmaceuticals arm of Johnson & Johnson, which created a breakthrough innovative program called Immersion. As part of this effort, they discovered that the majority of employees who were advising Janssen on emerging markets had never set foot in those countries. But it does happen.

Innovation 12

Innovation P&L Short-term Company 12

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. But now the situation has reached such a tipping point that larger U.S. manufacturers are taking notice.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

JUNE 16, 2016

In July 2015, Novartis launched its new heart failure drug, Entresto, which Forbes in 2014 predicted would be a blockbuster — with expected sales of $10 billion annually — as the potential market in the US exceeds 5 million people with a heart failure condition. The failure stemmed from resistance in the U.S.

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Resistant forms continue to thrive, and increased travel makes the global threat very real. Redefine ROI.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

SEPTEMBER 13, 2016

A heavy manufacturing company was facing a downturn in its markets and the potential of sizable layoffs. He did it personally, rather than through a series of e-mails, and so did his team: the top 50 leaders of the site spent hours on the factory floor listening to ideas. There was massive variance in how these sessions ran.

Resistance 8

Resistance Influence Pharmaceuticals Bottom-up 8

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Executive teams need to assess their industries’ and companies’ time horizons for the technology, because they will have a huge amount of strategic and business process planning to do before their companies adopt it.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

JULY 7, 2011

Otherwise positive and productive team members begin to dread coming to work, and the group's best thinking gets siphoned off the company's mission as everyone scrambles to stay out of the bully's crosshairs. Roger, a vice president of sales and marketing in the pharmaceutical industry, was one such Pleaser.

Rogers 15

Rogers Morale Long-term Pharmaceuticals 15

Harvard Business Review

DECEMBER 14, 2015

As CEO of the TLEX Institute, Johann Berlin specializes in bringing mindfulness training to CEOs and corporate teams. “There was this one instance where the market tanked and there was panic on the desk. ” You and Your Team. “I didn’t tend to understand what my team was going through. Mindfulness.

CEO 8

CEO Emotional Intelligence Cooper Pharmaceuticals 8

Harvard Business Review

JUNE 22, 2016

In today’s market, tech platforms enable IP and relationships to scale rapidly, and at near-zero cost. For example, do you make and sell things, hire skilled employees and provide services, develop and new IP like software or pharmaceuticals, or build and manage digital networks, be they transactional, informational, or social?

Intangible Assets 10

Intangible Assets Business Model How To Intellectual Capital 10

Harvard Business Review

JANUARY 5, 2018

But over and over again in our three decades of experience as talent development and retention specialists, we’ve seen that companies consistently overlook half of them. These are jobs in R&D, technology, and other areas vital to a firm’s strategic direction, product development, and process efficiency.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

FEBRUARY 24, 2015

The first category is exogenous factors over which the business has little control: the growth of the markets into which it sells; the competitive intensity and thus the average profitability of the industry in which it operates; or the fragmentation of its industry and thus the scope for a growth-by-acquisition approach.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines.

Globalization 10

Globalization Innovation Decentralization Chemicals 10

Harvard Business Review

NOVEMBER 9, 2011

That's what we found when we studied the top management teams of companies in Europe over the past three years. The COO's role, we find, is driven by three factors: the company's strategy, the composition of the executive team, and the relationships between the members of the top team.

COO 13

COO Sample Telecommunications Automotive 13

Harvard Business Review

JANUARY 8, 2013

arm of pharmaceuticals manufacturer Boehringer Ingelheim (BIPI). He emailed Christopher Tan, a marketer with an interest in mobile technologies and experience building applications, and within 36 hours, they had come up with a prototype. But, as we all know, bridging interdepartmental chasms is far easier said than done.

Company 9

Company Pharmaceuticals Health Care Participative 9

Harvard Business Review

MAY 8, 2013

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. MLMs can also take the initiative here, forming their own teams with other MLMs.

Middle Management 9

Middle Management Management Automotive Pharmaceuticals 9

Harvard Business Review

APRIL 13, 2015

Warren Buffett has earned his nickname because he’s proven time and again that he has an eye for predicting how markets will change and which companies will succeed in the aftermath. When markets or technologies change, it often requires entire segments of the value network to be reimagined. What’s changed?

Software 8

Software Trends Mass Marketing Marketing 8

Harvard Business Review

DECEMBER 23, 2016

What distinguished successful from unsuccessful alliances was more of a “productive” irritation — creative tension between differing ideas about how to develop alliance products – reflected in disagreements about the strategy and tactics of how best to develop a particular molecule.

Productivity 8

Productivity Products Survey Strategic Fit 8

Harvard Business Review

OCTOBER 21, 2013

I found myself reflecting on this recently while speaking with two business leaders in one of the world’s great pharmaceutical companies. Strength in Diverse, Collaborative Teams. These firms lacked diverse, highly collaborative leadership teams. It’s a tough challenge.

Drucker 8

Drucker Diversity Pharmaceuticals Uncertainty 8